A new jab that can help obese adults lose 15 per cent of their body weight is set to be made more widely available on the NHS, after the government announced it was exploring ways for patients to receive it without having to go to hospital.
NICE, the body which rules on the cost-effectiveness of novel medicines, earlier this year approved the new drug, semaglutide, but said it should be available only through specialist weight-management services, most of which are in hospitals.
您已閱讀21%（641字），剩余79%（2473字）包含更多重要信息，訂閱以繼續探索完整內容，并享受更多專屬服務。